Literature DB >> 19251133

Corneal collagen crosslinking using riboflavin and ultraviolet-A light for keratoconus: one-year analysis using Scheimpflug imaging.

Dilraj S Grewal1, Gagandeep S Brar, Rajeev Jain, Vardaan Sood, Mohit Singla, Satinder Pal Singh Grewal.   

Abstract

PURPOSE: To evaluate changes in corneal curvature, corneal elevation, corneal thickness, lens density, and foveal thickness after corneal collagen crosslinking with riboflavin and ultraviolet-A (UVA) light in eyes with progressive keratoconus.
SETTING: Grewal Eye Institute, Chandigarh, India.
METHODS: Subjective refraction, best corrected visual acuity (BCVA), Scheimpflug imaging, and optical coherence tomography were performed preoperatively and 1 week, 1, 3, and 6 months, and 1 year after crosslinking.
RESULTS: There were no significant differences (P > 0.05) in mean values between preoperatively and 1 year postoperatively, respectively, in BCVA (0.22 +/- 0.10 and 0.20 +/- 0.10), spherical equivalent (-6.30 +/- 4.50 diopters (D) and -4.90 +/- 3.50 D), or cylinder vector (1.58 x 7( degrees ) +/- 3.8 D and 1.41 x 24( degrees ) +/- 3.5 D). There was no significant difference in mean measurements between preoperatively and 1 year postoperatively, respectively, for central corneal thickness (458.9 +/- 40 microm and 455.2 +/- 48.6 microm), anterior corneal curvature (50.6 +/- 7.4 D and 51.5 +/- 3.6 D), posterior corneal curvature (-7.7 +/- 1.2 D and -7.4 +/- 1.1 D), apex anterior (P = .9), posterior corneal elevation (P = .7), lens density (P = .33), or foveal thickness (175.7 +/- 35.6 microm and 146.4 +/- 8.5 microm; P = .1).
CONCLUSIONS: Stable BCVA, spherical equivalent, anterior and posterior corneal curvatures, and corneal elevation 1 year after crosslinking indicate that keratoconus did not progress. Unchanged lens density and foveal thickness suggest that the lens and macula were not affected after UVA exposure during crosslinking.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251133     DOI: 10.1016/j.jcrs.2008.11.046

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  48 in total

1.  Effects of corneal cross-linking on ocular response analyzer waveform-derived variables in keratoconus and postrefractive surgery ectasia.

Authors:  Katie M Hallahan; Karolinne Rocha; Abhijit S Roy; J Bradley Randleman; R Doyle Stulting; William J Dupps
Journal:  Eye Contact Lens       Date:  2014-11       Impact factor: 2.018

Review 2.  Corneal collagen crosslinking in keratoconus and other eye disease.

Authors:  Adel Alhayek; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

Review 3.  Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies.

Authors:  Maria Gkika; Georgios Labiris; Vassilios Kozobolis
Journal:  Int Ophthalmol       Date:  2011-08-17       Impact factor: 2.031

4.  Corneal collagen crosslinking for keratoconus or corneal ectasia without epithelial debridement.

Authors:  N Hirji; E Sykakis; F C Lam; R Petrarca; S Hamada; D Lake
Journal:  Eye (Lond)       Date:  2015-03-20       Impact factor: 3.775

Review 5.  Treatment strategies for corneal ectasia.

Authors:  Jennifer G Bromley; J Bradley Randleman
Journal:  Curr Opin Ophthalmol       Date:  2010-07       Impact factor: 3.761

Review 6.  Current perspectives on corneal collagen crosslinking (CXL).

Authors:  Sandeepani K Subasinghe; Kelechi C Ogbuehi; George J Dias
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-06       Impact factor: 3.117

Review 7.  Safety and efficacy of epithelium removal and transepithelial corneal collagen crosslinking for keratoconus.

Authors:  Z Shalchi; X Wang; M A Nanavaty
Journal:  Eye (Lond)       Date:  2014-10-03       Impact factor: 3.775

8.  The Long-term Clinical Outcome after Corneal Collagen Cross-linking in Korean Patients with Progressive Keratoconus.

Authors:  Tae Gi Kim; Ki Young Kim; Jung Bin Han; Kyung Hyun Jin
Journal:  Korean J Ophthalmol       Date:  2016-09-29

9.  Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis.

Authors:  G Pron; L Ieraci; K Kaulback
Journal:  Ont Health Technol Assess Ser       Date:  2011-11-01

10.  Factors affecting outcomes of corneal collagen crosslinking treatment.

Authors:  I Toprak; V Yaylalı; C Yildirim
Journal:  Eye (Lond)       Date:  2013-10-18       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.